Table 5.

Changes in anthropometric and metabolic variables in response to the 12-week nutritional intervention programme

	Men (n 57)			Women (n 51)			Men v. women differences		Men v. women differences adjusted for baseline value
Variables	Δ 0–12 weeks	% Change from baseline	P	Δ 0–12 weeks	% Change from baseline	P	Mean	95 % CI	Mean	95 % CI
Body weight (kg)	−1·0	−1·0	0·0003	−0·6	−0·8	0·06	−0·5	−1·3, 0·3	−0·6	−1·6, 0·3
BMI (kg/m2)	−0·3	−1·0	0·0004	−0·2	−0·7	0·03	−0·1	−0·4, 0·1	−0·1	−0·4, 0·1
Body fat (%)‡	−0·7	−2·6	0·003	−0·2	−0·5	0·31	−0·4	−1·0, 0·2	−0·4	−1·4, 0·6
Waist circumference (cm)	−1·3	−1·2	0·01	−1·1	−1·1	0·04	−0·2	−1·7, 1·3	0·02	−1·7, 1·7
HDL-C (mmol/l)	0·05	4·5	0·005	0·01	0·7	0·42	0·04	−0·01, 0·08	0·007	−0·05, 0·06
LDL-C (mmol/l)	−0·03	−0·8	0·62	−0·06	−1·7	0·43	0·02	−0·2, 0·2	0·05	−0·1, 0·2
ApoB (g/l)	−0·02	−1·7	0·33	−0·01	−0·9	0·58	−0·007	−0·05, 0·04	0·002	−0·04, 0·05
Total-C:HDL-C ratio	−0·3	−5·9	< 0·0001	−0·1	−2·4	0·13	−0·2†	−0·4, −0·03	−0·08	−0·3, 0·1
TAG (mmol/l)*§	−0·3	−15·8	0·0002	−0·09	−6·0	0·20	−0·2	−0·4, 0·03	0·01	−0·2, 0·2
TAG:HDL-C ratio*§	−0·3	−16·7	< 0·0001	−0·08	−7·3	0·26	−0·2†	−0·4, −0·04	0·03	−0·1, 0·2
Systolic blood pressure (mmHg)	1·0	0·8	0·41	0·4	0·4	0·74	0·6	−3·0, 4·2	3·9	0·5, 7·4
Diastolic blood pressure (mmHg)	−2·4	−3·2	0·01	−1·6	−2·3	0·10	−0·8	−3·3, 1·8	0·6	−1·9, 3·1
Fasting glucose (mmol/l)*§	0·04	0·8	0·56	0·04	0·8	0·50	−0·007	−0·2, 0·2	0·02	−0·1, 0·2
Fasting insulin (pmol/l)	−1·6	−1·6	0·61	0·4	0·5	0·91	−2·0	−11·2, 7·1	0·3	−8·3, 8·8

Δ 0–12 weeks, Change following the 12-week nutritional intervention programme; HDL-C, HDL-cholesterol; LDL-C, LDL-cholesterol; total-C, total cholesterol.

* Significant interaction between gender and baseline value (P ≤ 0·05).

† Significant differences in men v. women between 0–12 weeks without adjustment for the baseline value (P ≤ 0·05).

‡ Men (n 52) and women (n 48) because of missing values.

§ Analysis was performed on transformed values.